AHRQ review finds mindfulness helps children with anxiety and depression

The federal reality check is here: mindfulness-based interventions can help some children and adolescents with anxiety, depression and behavior problems, but the gains are small, short-term and far from a cure-all. The new systematic review from the Agency for Healthcare Research and Quality, posted by its Effective Health Care program on May 20, 2026, examined mindfulness-based interventions alongside acceptance and commitment therapy for young people and found the clearest signal among children with diagnosed conditions.

That matters because AHRQ’s own protocol laid out a sizable need. It cited the 2020 National Survey of Children’s Health, where 8.5% of children ages 3 to 17 had an anxiety disorder and 3.8% had a depression disorder. It also pointed to Centers for Disease Control and Prevention data showing 40% of U.S. children ages 12 to 17 have at least one chronic health condition, while only about 48% of adolescents with depression received treatment in 2022. In other words, the review lands in a system where need is high and access remains uneven.

AHRQ started building the review well before publication. The protocol was initially published on June 26, 2024 and amended on February 5, 2025. The agency also asked for supplemental evidence through a Federal Register notice on July 2, 2024, with an August 1, 2024 deadline. That long runway underscores how much federal attention is being placed on whether mindfulness and ACT can offer practical options for families, schools and clinics.

The Patient-Centered Outcomes Research Institute said it partnered with AHRQ on the review, and that the Academic Consortium for Integrative Medicine and Health and the American Academy of Pediatrics intended to use the evidence review to inform clinical practice guidance. PCORI also said nearly 12% of parents in the United States report using integrative therapies for children, and it cited pandemic-era estimates that up to one in five children and adolescents experienced clinically significant depression and as many as one in four experienced anxiety.

AHRQ has been saying for months that the bigger problem is not just finding treatments, but finding the right treatment for the right child. In July 2025, its youth mental health newsletter said research still leaves gaps in answering “what is the best treatment for whom,” a reminder that the new mindfulness review should be read as a guide to modest, testable support, not as a promise of transformation.